Core Viewpoint - Nukkleus, Inc. has regained compliance with Nasdaq's market value requirements, allowing its securities to continue being listed and traded on the Nasdaq Stock Market [1][2][3] Group 1: Compliance and Listing Status - Nukkleus was notified on January 15, 2025, that it has regained compliance with Nasdaq Listing Rule 5450(b)(2)(A) and 5450(b)(2&3)(C) [1] - As a result, Nasdaq has canceled the hearing scheduled for January 21, 2025, confirming the continuation of Nukkleus's listing [2] - This milestone reflects Nukkleus's commitment to meeting Nasdaq's compliance standards [2][3] Group 2: Company Overview and Strategy - Nukkleus, Inc. focuses on innovative acquisition strategies, targeting high-potential businesses across sectors such as defense, financial services, real estate, industrial, and technology [4] - The company aims to drive growth, innovation, and operational excellence through strategic investments and expertise [4] - Nukkleus leverages market insights and advanced solutions to accelerate growth and ensure long-term success for its portfolio businesses [4]
Nukkleus Inc. Successfully Resolves Nasdaq Delisting Threat, Achieving Compliance Across All Key Parameters